Arcutis Biotherapeutics Cash from Financing (TTM) Trends

Arcutis Biotherapeutics Inc (ARQT)

8.60 -0.23 (-2.60%) USD | NASDAQ | May 02, 16:00

8.60 0.00 (0.00%) After-Hours: 17:46

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	101.32M
September 30, 2023	2.996M
June 30, 2023	287.12M
March 31, 2023	287.18M
December 31, 2022	301.80M
September 30, 2022	373.72M
June 30, 2022	88.79M
March 31, 2022	88.85M
December 31, 2021	281.95M

Date	Value
September 30, 2021	338.45M
June 30, 2021	337.95M
March 31, 2021	337.07M
December 31, 2020	298.14M
September 30, 2020	261.72M
June 30, 2020	262.14M
March 31, 2020	262.00M
December 31, 2019	93.10M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.996M

Minimum

Sep 2023

373.72M

Maximum

Sep 2022

235.55M

Average

281.95M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks